Oluseyi Babatope Abidoye

Oluseyi Abidoye practices at Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic.

Oluseyi Abidoye's NPI, 1780211029, was assigned on March 26, 2020. Oluseyi Abidoye holds Arizona license 69254.

Oluseyi Abidoye's primary practice is Mayo Clinic Hospital - Phoenix, at 5777 East Mayo Boulevard, Phoenix, AZ 85054 in Maricopa County. The practice phone is (480) 342-4201.

Oluseyi Abidoye's primary practice is Mayo Clinic Hospital - Phoenix in Phoenix, Arizona, part of Mayo Clinic. The medical group on file is Mayo Clinic Arizona.

Dmand AI tracks the electronic health record (EHR) system at each site where Oluseyi Abidoye practices. Vendor and product names are available with a free account.

Hematology and oncology is Oluseyi Abidoye's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Oluseyi Abidoye is licensed in Arizona.

CMS data shows 20 Medicare services from Oluseyi Abidoye across 1 procedure code in 2024, all of them office visits, for 18 Medicare patients. Medicare paid $1,843 for them. Every service was in an office.

CMS counts 18 Medicare patients who saw Oluseyi Abidoye in 2024. The largest group is under 65, with 0 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Oluseyi Abidoye's median patient age at 72, with 48% women.

In 2024, Oluseyi Abidoye wrote 126 Medicare Part D claims for 37 patients. 89% of them were for generic drugs. CMS names the drug for 71 of them, across 4 drugs with 11 or more claims each, at $801 in total drug cost. In 2023, CMS named 74 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Oluseyi Abidoye for performance year 2024, reported as part of a group. Oluseyi Abidoye accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Oluseyi Abidoye, published from 2017 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Antibodies, Monoclonal, Antineoplastic Combined Chemotherapy Protocols and Biliary Tract Neoplasms. Oluseyi Abidoye has published most often in Cureus. Oluseyi Abidoye's most frequent co-authors are Tanios S. Bekaii-Saab, MD, Mitesh J. Borad, MD and Mohamad Bassam Sonbol, MD.

CMS Open Payments shows 4 general payments to Oluseyi Abidoye from 2 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 51% of the total. Takeda Pharmaceuticals U.S.A., Inc. paid the most, $146.